544 related articles for article (PubMed ID: 9070312)
1. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: comparative analysis of carbohydrate structures and the antigen presenting cell.
González-Fernández M; Carrasco-Marín E; Alvarez-Domínguez C; Outschoorn IM; Leyva-Cobián F
Cell Immunol; 1997 Feb; 176(1):1-13. PubMed ID: 9070312
[TBL] [Abstract][Full Text] [Related]
2. Wortmannin, an inhibitor of phospholipase D activation, selectively blocks major histocompatibility complex class II-restricted antigen presentation.
Carrasco-Marín E; Alvarez-Domínguez C; Leyva-Cobián F
Eur J Immunol; 1994 Sep; 24(9):2031-9. PubMed ID: 8088323
[TBL] [Abstract][Full Text] [Related]
3. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells are the most efficient in presenting endogenous naturally processed self-epitopes to class II-restricted T cells.
Guéry JC; Adorini L
J Immunol; 1995 Jan; 154(2):536-44. PubMed ID: 7529278
[TBL] [Abstract][Full Text] [Related]
5. Functional differences and complementation between dendritic cells and macrophages in T-cell activation.
Guidos C; Sinha AA; Lee KC
Immunology; 1987 Jul; 61(3):269-76. PubMed ID: 2956179
[TBL] [Abstract][Full Text] [Related]
6. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.
Böhm W; Schirmbeck R; Elbe A; Melber K; Diminky D; Kraal G; van Rooijen N; Barenholz Y; Reimann J
J Immunol; 1995 Oct; 155(7):3313-21. PubMed ID: 7561024
[TBL] [Abstract][Full Text] [Related]
7. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
Singh SK; Stephani J; Schaefer M; Kalay H; García-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
[TBL] [Abstract][Full Text] [Related]
8. Downmodulation of antigen presentation by H2-O in B cell lines and primary B lymphocytes.
Brocke P; Armandola E; Garbi N; Hämmerling GJ
Eur J Immunol; 2003 Feb; 33(2):411-21. PubMed ID: 12645938
[TBL] [Abstract][Full Text] [Related]
9. Class II MHC molecules are spontaneously internalized in acidic endosomes by activated B cells.
Weber DA; Buck LB; Delohery TM; Agostino N; Pernis B
J Mol Cell Immunol; 1990; 4(5):255-66; discussion 266-8. PubMed ID: 2169757
[TBL] [Abstract][Full Text] [Related]
10. MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells.
Kleijmeer MJ; Ossevoort MA; van Veen CJ; van Hellemond JJ; Neefjes JJ; Kast WM; Melief CJ; Geuze HJ
J Immunol; 1995 Jun; 154(11):5715-24. PubMed ID: 7751623
[TBL] [Abstract][Full Text] [Related]
11. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
12. Intrathymic presentation by dendritic cells and macrophages: their role in selecting T cells with specificity for internal and external nominal antigen.
Zöller M
Immunology; 1991 Nov; 74(3):407-13. PubMed ID: 1722772
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
14. Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules.
Brazil MI; Weiss S; Stockinger B
Eur J Immunol; 1997 Jun; 27(6):1506-14. PubMed ID: 9209504
[TBL] [Abstract][Full Text] [Related]
15. Contrasting cytoskeletal regulation of MHC class II peptide presentation by human B cells or dendritic cells.
Delaguillaumie A; Marin-Esteban V; Setterblad N; Leh LJ; Assier E; Gelin C; Charron D; Galy A; Mooney N
Eur J Immunol; 2008 Apr; 38(4):1096-105. PubMed ID: 18393378
[TBL] [Abstract][Full Text] [Related]
16. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages.
Matousek MP; Nedrud JG; Harding CV
J Immunol; 1996 Jun; 156(11):4137-45. PubMed ID: 8666780
[TBL] [Abstract][Full Text] [Related]
17. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation.
Maurer D; Fiebiger E; Reininger B; Ebner C; Petzelbauer P; Shi GP; Chapman HA; Stingl G
J Immunol; 1998 Sep; 161(6):2731-9. PubMed ID: 9743330
[TBL] [Abstract][Full Text] [Related]
18. Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.
Rodriguez A; Regnault A; Kleijmeer M; Ricciardi-Castagnoli P; Amigorena S
Nat Cell Biol; 1999 Oct; 1(6):362-8. PubMed ID: 10559964
[TBL] [Abstract][Full Text] [Related]
19. Macrophage presentation of endogenous self-protein: the MHC class II presentation pathway is not accessible to intracellular C5 or alpha 1-antitrypsin.
Grant CF; Ali R; Povey S; Stockinger B
Cell Immunol; 1996 Feb; 167(2):230-40. PubMed ID: 8603432
[TBL] [Abstract][Full Text] [Related]
20. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
